Conavi Patent Portfolio

The products listed on this website, either alone or in combination with other product(s), are protected by one or more of the identified patents and/or patent applications. Additional patents may be issued and/or pending the U.S. or elsewhere. The following list of Conavi Medical Inc. products may not be all inclusive, and other Conavi Medical Inc. products not listed here may be protected by one or more patents.

US Patent Numbers:

8,214,010 8,460,195 9,375,147 10,667,785 8,784,321 11,147,452 8,712,506 9,357,923 9,039,626 10,729,376 9,700,280 10,390,791 11,364,009 10,328,463 11,051,761 10,482,582 10,902,564 9,076,202 9,387,305 9,839,410 10,105,918 9,786,056 10,699,411

CA Patent Numbers:

2,675,619 2,675,617 2,824,955 2,815,580 3,085,777 2,836,653

CN Patent Numbers:

ZL 200880009253.8 ZL 201310015205.2 ZL 201710183540.1 ZL 200880009104.1 ZL 201410333307.3 ZL 201710304705.6 ZL 201480063198.6 ZL 201680048364.4 ZL 201780024112.2 ZL 201280036143.7 ZL 201610278648.4

JP Patent Numbers:

5224545 5695109 6018236 6353001 JP6727251 5784649 6068572 6538956 6878499 6440359 6445076 6621745 6821604 6923545 6371421 6673985 7069236 6073295 6464102 6393698 6611880 6450328

The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The Novasight Hybrid System is cleared for sale in the following jurisdictions (regulatory approvals referenced): • United States: FDA 510(k) clearance (K172258) • Canada: Health Canada medical device license (102500) • Japan: PMDA medical device license (catheter: 30200BZX00040000, console + PIM: 30200BZX00039000) ISI: conavi.com/novasight/isi